Metastatic Gastrointestinal Stromal Tumor
Also known as: Metastatic Gastrointestinal Stromal Tumor (GIST)
Drug | Drug Name | Drug Description |
---|---|---|
DB15233 | Avapritinib | A selective tyrosine kinase inhibitor being investigated for the treatment of multidrug resistant gastrointestinal tumors. |
DB00619 | Imatinib | A tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors. |
DB08896 | Regorafenib | A kinase inhibitor used to treat patients with metastatic colorectal cancer, unresectable, locally advanced, or metastatic gastrointestinal stromal tumors, and hepatocellular carcinoma. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00619 | Imatinib | 1 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
DB11595 | Atezolizumab | 2 | Recruiting | 1 |
DB08875 | Cabozantinib | 2 | Completed | 1 |
DB00619 | Imatinib | 2 | Recruiting | 2 |
DB15078 | Rogaratinib | 2 | Active Not Recruiting | 1 |